Literature DB >> 11533999

The Raymond Pearl memorial lecture, 1997: The quest for medical normalcy-who needs it?

George C. Williams1.   

Abstract

Darwinian natural selection is the only factor in evolution that maintains and improves adaptation. It does so by favoring genes that enhance the genetic success of their bearers under historically prevalent conditions, and need not favor health or happiness or conformity to some universally normal state. It may favor unpleasant departures from medical normalcy if they contribute to long-term genetic success, either directly or as unavoidable costs of features that make such contributions. It is also blind to future consequences of current evolution, so that every evolving lineage accumulates historical legacies that may seriously constrain future adaptation. Examples of adaptive but unpleasant abnormality are found in infectious diseases and other instances of conflict (between the sexes, between parent and offspring, between competitors for limited resources). Examples of unfortunate historical legacies are found in limitations on numbers of parts (limbs, sense organs) and in the tight human birth passage. Adaptation is a more useful medical concept than normalcy, but the purpose of medicine is not to facilitate natural selection or uncritically encourage biological adaptations. Medical intervention may legitimately promote human values by frustrating adaptations (e.g., by anesthesia) or by seeking the grossly abnormal (e.g., birth through the abdomen rather than the vagina). Am. J. Hum. Biol. 12:10-16, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Year:  2000        PMID: 11533999     DOI: 10.1002/(SICI)1520-6300(200001/02)12:1<10::AID-AJHB2>3.0.CO;2-N

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  1 in total

1.  Evolutionary explanations in medical and health profession courses: are you answering your students' "why" questions?

Authors:  Eugene E Harris; Avelin A Malyango
Journal:  BMC Med Educ       Date:  2005-05-10       Impact factor: 2.463

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.